Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001683168-22-001762
Filing Date
2022-03-18
Accepted
2022-03-18 07:58:55
Documents
1
Effectiveness Date
2022-03-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10058
  Complete submission text file 0001683168-22-001762.txt   11467
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-437864 | Film No.: 22751083
SIC: 8731 Services-Commercial Physical & Biological Research